Photo from wikipedia
An aggressive treatment, including immunomodulatory therapy, is very important in preventing the development of the chronic recurrent stage in Vogt-Koyanagı-Harada (VKH) disease. However, the way of treatment is not the… Click to show full abstract
An aggressive treatment, including immunomodulatory therapy, is very important in preventing the development of the chronic recurrent stage in Vogt-Koyanagı-Harada (VKH) disease. However, the way of treatment is not the only factor determining the prognosis, and there are other factors that affect the outcome.
Keywords:
editor response;
disease;
reply letter;
letter editor;
response comment;
authors reply
Journal Title: Ocular immunology and inflammation
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Ocular immunology and inflammation
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!